Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Low body weight linked to PML risk with natalizumab in MS
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Neuromyelitis optica and pregnancy.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Induction of intestinal Th17 cells by segmented filamentous bacteria.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Transverse myelitis following combined spinal-epidural anesthesia.
Association of smoking with risk of multiple sclerosis: a population-based study.
MicroRNA-21 with therapeutic potential in autoimmune diseases.
Available evidence and outcome of off-label use of rituximab in clinical practice.
The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
Fluoxetin Upregulates Connexin 43 Expression in Astrocyte.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
How microglia kill neurons.
Prediction of antibody persistency from antibody titres to natalizumab.
Central nervous system B-cell lymphoma in multiple sclerosis.
FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.

Pages